| 1. |
- McKelvey, Maureen, 1965, et al.
(författare)
-
Effects of position in research network on innovative performance: Evidence the Pharmaceutical Industry
- 2012
-
Ingår i: International Schumpeter Conference, Brisbane, Australia, July 2012.
-
Konferensbidrag (refereegranskat)abstract
- This paper explores how and why collaboration with different types of partners and the position within a research network can affect firms’ innovative performance in terms of product innovations. A detailed empirical analysis is carried out in the biotechnology and pharmaceutical industry. This industry is characterized by a rapidly developing, complex, and dispersed knowledge base, where one would expect positive benefits from collaboration and the position within a network for innovative output. The paper uses a unique dataset in pharmaceutical cancer research based on scientific co-publications and new drug approvals. We apply social network analysis and count data regressions. We observe that collaboration with a diverse set of partners from academia and the network position in terms of eigenvector centrality is positively related to product innovation. However, we do not find a general positive association between collaboration, particularly with biotechnology companies, and product innovation or between central network positions and product innovation. Therefore, these results require a re-assessment of the role of scientific collaboration and biotechnology companies in the development of the pharmaceutical industry.
|
|
| 2. |
- McKelvey, Maureen, 1965, et al.
(författare)
-
Research network position and innovative performance: Evidence from the pharmaceutical industry
- 2013
-
Ingår i: Workshop on the role of hospitals in innovation, Center for Technology, innovation and culture, University of Oslo.
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
- Building upon the literature demonstrating the importance of collaborative research and networks for the development of new pharmaceuticals, this paper describes co-publication networks in phar- maceutical cancer research and analyzes how the position within these networks and collaboration with different partners is related to the product innovation of both pharmaceutical and biotechnol- ogy firms. This paper analyzes these issues through econometric analysis as well as social network analysis using a unique dataset based on scientific co-publications, new drug approvals, and firm level data. We observe that the number of organizations in co-publication networks expands faster than the collaborations within the networks. Global pharmaceutical companies tend to be highly connected and occupy central positions in the co-publication networks. Direct and indirect linkages, particularly to academic institutions, are beneficial for product innovations. In contrast to most of the existing literature, we find that co-publication of pharmaceutical companies with biotechnol- ogy companies is a rather rare event – and we do not find a significant association to the firm’s innovative performance.
|
|
| 3. |
- McKelvey, Maureen, 1965, et al.
(författare)
-
The influence of collaboration on firm publications: Evidence from pharmaceutical cancer research
- 2014
-
Ingår i: Conference Innovation and Entrepreneurship in Health Care & Life Sciences. 2nd annual InnovHealth network..
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
- This paper addresses whether, and how, collaboration in research affects the firm's later propensity to get a new drug approved. Cancer is in focus. This paper was presented at the Conference Innovation and Entrepreneurship in Health Care & Life Sciences. 2nd annual InnovHealth network. IIE organized this conference, 11-12 Dec 2014, Gothenburg, Sweden.
|
|
| 4. |
|
|
| 5. |
- McKelvey, Tomas, 1966, et al.
(författare)
-
Product Innovation Success Based on Cancer Research in the Pharmaceutical Industry: Co-publication networks and the effects of partners
- 2016
-
Ingår i: Industry and Innovation. - : Informa UK Limited. - 1366-2716 .- 1469-8390. ; 23:5, s. 383-406
-
Tidskriftsartikel (refereegranskat)abstract
- This paper builds upon the literature which provides conflicting theoretical insights and empirical results concerning the importance of companies’ collaborative relations, their position within a network of collaborative relations and the effects on their innovative performance. Taking the importance of collaborations and networks in the pharmaceutical industry into account, the paper untangles the influence of the firm’s co-publication relations with different types of partners and its network position on the company’s product innovation in a specific disease area—cancer. We find rather robust evidence that in particular, companies’ indirect connections within the co-publication network, including connections to academic institutions and biotechnology companies, support product innovation. In contrast to evidence in the strategic alliance literature, direct co-publication links to biotechnology companies do not support product innovation in terms of new cancer medications.
|
|
| 6. |
- McKelvey, Tomas, 1966, et al.
(författare)
-
The influence of collaboration on firm publications: Evidence from pharmaceutical cancer research
- 2015
-
Ingår i: Academy of Management proceedings, Vancouver, Canada. Canada, 7-11 August 2015.. ; 2015:14244, s. 1-30
-
Konferensbidrag (refereegranskat)abstract
- Although bio-pharmaceutical companies engage intensely in collaboration as well as in scientific publications it is not well understood how and why the choice of distinct partner types affects the quality of companies’ scientific publications. We contribute to this gap in the existing literature by analyzing whether collaboration with particular types of partners and whether network embeddedness influences the quality of publications in cancer research, and specifically of the scientific publications of biotech and of pharmaceutical companies. Our empirical analysis employs two different measures for scientific quality, publication in top-tier journals and the number of forward citations. The results suggest that publication in top-tier journals may depend on different factors and collaboration patterns compared to the number of citations an article receives.
|
|
| 7. |
- McKelvey, Tomas, 1966, et al.
(författare)
-
The Influence of Collaboration on Firm Publications: Evidence from Pharmaceutical Cancer Research
- 2014
-
Ingår i: 15th International Conference of the International Joseph A. Schumpeter Society (ISS), hosted by the Friedrich Schiller University Jena, Germany, 27–30 July, 2014.. ; 2014:D10, s. 1-32
-
Konferensbidrag (refereegranskat)abstract
- Although bio-pharmaceutical companies engage intensely in collaboration as well as in scientific publications it is not well understood how and why the choice of distinct partner types affects the quality of companies’ scientific publications. We contribute to this gap in the existing literature by analyzing whether collaboration with particular types of partners and whether network embeddedness influences the quality of publications in cancer research, and specifically of the scientific publications of biotech and of pharmaceutical companies. Our empirical analysis employs two different measures for scientific quality, publication in top-tier journals and the number of forward citations. The results suggest that publication in top-tier journals may depend on different factors and collaboration patterns compared to the number of citations an article receives.
|
|
